Int Ophthalmol Clin. 2006 Fall;46(4):21-40.
Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug.
Donnenfeld ED, Donnenfeld A.
Rockville Centre, NY 11570, USA.
PMID: 17060789 [PubMed - indexed for MEDLINE]
Publication Types:
MeSH Terms:
Substances:
Full Text Sources:
Medical: